U.S. strike puts Venezuela natural gas in the spotlight as Eni says operations unaffected

U.S. strike puts Venezuela natural gas in the spotlight as Eni says operations unaffected

CARACAS, Jan 4, 2026, 12:46 ET

Italy’s Eni said on Sunday its natural gas operations in Venezuela have not been affected by Saturday’s U.S. strikes that captured President Nicolas Maduro, as energy companies assessed security and sanctions risk after Washington said it would oversee a political transition.  Reuters

The scramble matters because U.S. sanctions cover Venezuela’s oil and gas sector, forcing foreign operators to rely on U.S. authorizations — licenses that dictate whether projects can move, pay PDVSA, or export supplies. One of the biggest near-term prizes is gas, not crude: planned cross-border volumes that Trinidad and Tobago has sought to secure for its gas-dependent economy.  Reuters

Shell has aimed to start producing gas at Venezuela’s Dragon field and export it to Trinidad in 2026, Reuters has reported, a timeline driven by shortages at Trinidad’s liquefied natural gas (LNG) plants — facilities that chill gas into liquid for shipping. Atlantic LNG produced 8.5 million metric tons in 2024, about 4 million tons below installed capacity because of insufficient gas, according to LSEG data cited by Reuters.  Reuters

U.S. President Donald Trump said on Saturday the United States would put Venezuela under temporary American control after the raid that seized Maduro and took him to New York to face drug-trafficking charges. The overnight operation knocked out electricity in parts of Caracas and included strikes on military installations, Trump said.  Reuters

Venezuela’s oil exports are now paralyzed as port captains have not received requests to authorize loaded ships to set sail, four people close to operations told Reuters, highlighting the operational uncertainty around the country’s energy logistics. No tankers were loading on Saturday at the main oil port of Jose, TankerTrackers.com said.  Reuters

The U.S. Treasury authorization that revived the Dragon talks in October was structured in stages, with an initial phase allowing negotiations with Venezuela and PDVSA through April 2026 and requiring U.S. companies to be included, Trinidad’s attorney general said at the time. The same Reuters report said previous U.S. authorizations barred cash payments to Maduro’s government.  Reuters

Politics has repeatedly reset the project. In October, Maduro said Venezuela had suspended energy-development cooperation with Trinidad and Tobago — a move Reuters said would likely mean revoking the license to develop Dragon — after Caracas accused Trinidad’s new government of taking a pro-U.S. stance.  Reuters

Venezuela’s state-run oil production and refining were operating normally and suffered no damage from the U.S. attack, two sources with knowledge of PDVSA’s operations told Reuters, though the port of La Guaira near Caracas was reported to have suffered severe damage. Trump had announced a blockade of oil tankers in December and the U.S. seized two cargoes of Venezuelan oil, Reuters reported.  Reuters

But a fast rebound in cross-border gas work is far from assured, even if fields and platforms keep running. “History shows that forced regime change rarely stabilises oil supply quickly, with Libya and Iraq offering clear and sobering precedents,” said Jorge Leon, head of geopolitical analysis at Rystad Energy, in a Reuters analysis.  Reuters

Markets and regional energy buyers are watching Maduro’s initial appearance in Manhattan federal court on Monday, Jan. 5, which a U.S. Justice Department official told Reuters was expected. Investors are also looking for the next U.S. policy signal on the sanctions waivers that govern whether gas projects such as Dragon can proceed beyond negotiations.  Reuters

Stock Market Today

  • Intuitive Surgical valuation near fair value after strong run
    January 6, 2026, 8:55 PM EST. Intuitive Surgical (ISRG) appears near its narrative fair value of $596.36, with a last close of $592.85. The gap is small despite a 90-day return of 32.3% and a 5-year TSR of 125.6%. The narrative attributes value to ongoing product innovation-da Vinci 5, integrated force feedback, and AI-driven case insights-that could lift procedure growth, system ASPs, and recurring instrument revenues. Risks include tariff-related margin pressure and tighter hospital budgets in key international markets. The stock's forward P/E at about 76.5x sits well above the Medical Equipment group (≈29.9x) and peers, implying a premium. The question: is that premium justified by the outlook for growth and margins?
Pegasystems stock slides 6% to start 2026 as insider sale filing lands — what’s next for PEGA
Previous Story

Pegasystems stock slides 6% to start 2026 as insider sale filing lands — what’s next for PEGA

EQT stock slips as U.S. natural gas prices fall on warmer forecast — what traders watch next
Next Story

EQT stock slips as U.S. natural gas prices fall on warmer forecast — what traders watch next

Go toTop